ARWR Latest Headlines

Ionis upgraded at BMO on Tryngolza adoption for severe hypertriglyceridemia

at seekingalpha.com (Wed, 21-Oct 5:21 PM)

Arrowhead Pharmaceuticals (ARWR) Gets a Buy from UBS

at www.tipranks.com (Wed, 21-Oct 6:38 AM)

ARWR Highlights ARO-MAPT’s 73% Mean Tau Reduction at Day 105, Pointing to Potential Quarterly Dosing

Market Chameleon (Wed, 14-Oct 8:11 AM)

Arrowhead Pharmaceuticals Announces Fiscal Q3 Results Webcast, Spotlight on Pipeline and Strategic Direction

Market Chameleon (Wed, 22-Jul 11:07 AM)

Plozasiran Achieves Up to 81% Triglyceride Reduction in Arrowhead’s Phase 3 Studies—100% Drop in Acute Pancreatitis for Highest-Risk Patients

Market Chameleon (Wed, 22-Jul 7:51 AM)